简
繁
EN
简
繁
EN
Home
Latest
Finance
IPO
ETF
Technology
Overseas
Research
HOME
·
512290.SH
Guotai CSI BIOMEDICINE ETF(512290) Rises 3.11%, with Latest Net Capital Inflow of RMB 54.0455 Million
Tags：
ETF
512290.SH
Guotai CSI BIOMEDICINE ETF
2026-08-04
Guotai CSI BIOMEDICINE ETF (512290) Rises 1.41%, with Latest Margin Buying Amount Reaching RMB 9.8868 Million
Tags：
ETF
512290.SH
Guotai CSI BIOMEDICINE ETF
2026-07-29
Guotai CSI BIOMEDICINE ETF(512290) rises 2.63%, with the latest scale reaching 3.821 billion yuan
Tags：
ETF
512290.SH
Guotai CSI BIOMEDICINE ETF
2026-07-03
Guotai CSI BIOMEDICINE ETF(512290) Rises 3.86% in Morning Trading, Sees Net Inflow of 42.1030 Million Yuan Over the Past 10 Trading Days
Tags：
ETF
512290.SH
Guotai CSI BIOMEDICINE ETF
2026-04-28
Guotai CSI BIOMEDICINE ETF(512290) Rises 0.91% Intraday,Institutions Confirm Clear Industry Recovery Trend
Tags：
ETF
Guotai CSI BIOMEDICINE ETF
512290.SH
2026-04-15
Institutions: Optimistic on Pharmaceutical Catalytic Opportunities,Guotai CSI BIOMEDICINE ETF(512290) Rises 3.86% Intraday
Tags：
ETF
Guotai CSI BIOMEDICINE ETF
512290.SH
2026-04-01
Guotai CSI BIOMEDICINE ETF(512290) Rises 1.19% Intraday,Cautious Optimism with Accelerated M&A Layout
Tags：
ETF
Guotai CSI BIOMEDICINE ETF
512290.SH
2026-02-10
Biomedical Industry Enters Innovation 3.0 Era,Guotai CSI BIOMEDICINE ETF (512290) Pulls Back 1.40%
Tags：
ETF
512290.SH
Biomedical ETF
2026-01-19
Featured News
Research
HK Stock Connect Weekly Report: Hang Seng Index Rises 3.55% for the Week; Quarterly Review Results Unveiled, HUA HONG GRACE and ILUVATAR COREX Enter HSI and HSTECH - 20260821
Research
Going Global Weekly Report: Pharma Overseas Expansion Blossoms Across Fronts, A-Share Companies Accelerate Hong Kong Listings - 20260821
Research
HK Stock Connect Daily Report: MINIMAX-W Up Nearly 12%, Z.AI Up Over 10%, Southbound Net Sell of HKD 7.6 Billion - 20260821
Finance
Ingenic Semiconductor (03223.HK): H-Shares Offer Price Set at HK$100 Per Share
Finance
MOBVOI (02438.HK): Expects H1 Loss of RMB 45-58 Million
Finance
FAR INTL (02516.HK): Expects H1 Revenue Up 61%-110% and Turnaround or Narrower Loss
Finance
SHANDONG XINHUA (00719.HK): Obtains Drug Registration Certificate for Dapagliflozin Tablets
Finance
LEADS BIOLABS-B (09887.HK): NDA for Virexin as Treatment for Extrapulmonary Neuroendocrine Carcinoma Accepted by NMPA
Finance
SC HOLDINGS (00413.HK): Expects H1 Net Loss of HKD 400-500 Million
Finance
HK shares ETFs Daily Report: Gold Miners Extend Gains 5.7%! Blockchain and Korea Counterattack in Tandem, Biomedicine and MedTech Lead Declines - 20260821
Scan QR Code
Download App
